Triboluminescence instrument rapidly tests drug crystallinity
Researchers have created a device that can quickly and inexpensively determine whether new pharmaceutical formulations have trace crystallinity...
List view / Grid view
Researchers have created a device that can quickly and inexpensively determine whether new pharmaceutical formulations have trace crystallinity...
Advancement could streamline and boost scientific research all over the world, help computing industry...
A simple retinal prosthesis is being developed in hope that it can restore sight to blind people...
Scientists have developed a new test to diagnose peanut allergy that doesn't run the risk of false-positives or causing allergic reactions...
Industry's fastest level scan function and LabSolutions UV-Vis control software...
Researchers are developing a pill that makes tumours light up when exposed to infrared light...
Researchers create a device that allows more electron beam to pass through liquid samples...
The FDA has authorised the first test to identify the emerging pathogen Candida auris, which can cause serious infections in hospitalised patients...
Eurofins’ PSS Insourcing Solutions® (PSS) employs and manages full-time scientists, managers and support staff to perform a defined scope of work at a client’s facility.
Charles River Microbial Solutions believes data drives every decision in the lab, so ensuring it is accurate, relevant, and reliable is critical to support confident decisions on product quality and safety.
As the pioneers of the Limulus amebocyte lysate (LAL) testing methodology, Associates of Cape Cod, Inc., (ACC), specialises in bacterial endotoxin and (1→3)-ß-D-glucan detection, using Food and Drug Association-licensed chromogenic, turbidimetric and gel-clot reagent technologies.
A test of contrast-enhanced subharmonic imaging has shown promise in detecting prostate cancers that were not identified by MRI...
In this edition, five leading testing service providers explain how they cater for the pharmaceutical industry’s changing needs.
In this issue; recent developments in turning promising compounds into drug candidates, reviewing the latest trends in pharmaceutical microbiology and their implications, and a roundtable debate featuring the views of five industry leaders.